{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:45:13Z","timestamp":1773992713230,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.anndiagpath.2022.152006","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:39:48Z","timestamp":1657283988000},"page":"152006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-419X","authenticated-orcid":false,"given":"Jos\u00e9 C\u00e2ndido Caldeira","family":"Xavier-Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-3730","authenticated-orcid":false,"given":"Juliana Polizel","family":"Ocanha-Xavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152006_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.152006_bb0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5858\/arpa.2018-0038-RA","article-title":"Molecular testing for cutaneous melanoma: an update and review","volume":"143","author":"Lee","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0015","series-title":"WHO classification of skin tumours","year":"2018"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.152006_bb0020","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genomic Atlas Network","year":"2015","journal-title":"Cell"},{"issue":"7653","key":"10.1016\/j.anndiagpath.2022.152006_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152006_bb0030","doi-asserted-by":"crossref","first-page":"1.e1","DOI":"10.1016\/j.jaad.2012.02.047","article-title":"The dysplastic nevus: from historical perspective to management in the Morden era: part II: molecular aspects and clinical management","volume":"67","author":"Duffy","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0035","series-title":"Histological diagnosis of nevi and melanoma","author":"Massi","year":"2014"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152006_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00428-020-02817-5","article-title":"The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers","volume":"477","author":"Quiohilag","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0045","series-title":"Melanocytic nevi and melanoma: unraveling a complex relationship","first-page":"5771","volume":"36(42)","author":"Damsky","year":"2017"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152006_bb0050","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1055-9965.EPI-12-1346","article-title":"Dysplastic nevi and melanoma","volume":"22","author":"Goldstein","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1746-1596-6-76","article-title":"FISH as an effective diagnostic tool for the management of challenging melanocytic lesions","volume":"6","author":"Moore","year":"2011","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152006_bb0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaad.2015.04.029","article-title":"Dysplastic nevus: fact and fiction","volume":"73","author":"Rosendahl","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2022.152006_bb0065","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.jid.2015.11.035","article-title":"Discrimination of dysplastic nevi from common melanocytic nevi by cellular and molecular criteria","volume":"136","author":"Mitsui","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0070","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.24899","article-title":"Altered molecular pathways in melanocytic lesions","volume":"126","author":"Scatolini","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"1696","author":"Shain","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152006_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/ajd.13019","article-title":"Dysplastic\/Clark naevus in the era of molecular pathology","volume":"60","author":"Ardakani","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152006_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152006_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/jid.2013.316","article-title":"Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families","volume":"134","author":"Liang","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152006_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jid.2016.11.017","article-title":"Genomic characterization of dysplastic nevi unveils implications for diagnosis of melanoma","volume":"137","author":"Melamed","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152006_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/ada.2017.71119","article-title":"Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the polish population","volume":"34","author":"Mackiewicz-Wysocka","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"issue":"20","key":"10.1016\/j.anndiagpath.2022.152006_bb0105","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152006_bb0110","first-page":"28","article-title":"Melanoma: genetic abnormalities, tumor progression, clonal evolution and tumor initiating cells","volume":"5","author":"Testa","year":"2017","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0115","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study\u201d","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152006_bb0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/modpathol.2016.44","article-title":"MicroRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis","volume":"29","author":"Babapoor","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/981308","article-title":"Genome-wide analysis of gene and protein expression of dysplastic naevus cells","volume":"2012","author":"Gao","year":"2012","journal-title":"J Skin Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152006_bb0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.acthis.2011.11.001","article-title":"The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma","volume":"114","author":"Jiang","year":"2012","journal-title":"Acta Histochem"},{"issue":"9","key":"10.1016\/j.anndiagpath.2022.152006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072699","article-title":"In-depth characterization of microRNA transcriptome in melanoma","volume":"8","author":"Kozubek","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.anndiagpath.2022.152006_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107502","article-title":"A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion","volume":"9","author":"Babapoor","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152006_bb0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jdv.12148","article-title":"BRAF mutational epidemiology in dysplastic nevi: does different solar UV radiation exposure matter?","volume":"28","author":"Saroufim","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152006_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/his.13843","article-title":"Massively parallel sequencing analysis of benign melanocytic naevi","volume":"75","author":"Lozada","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152006_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12967-020-02253-8","article-title":"Clinical, pathological and dermoscopic phenotype of MITF p. E318K carrier cutaneous melanoma patients","volume":"18","author":"Ciccarese","year":"2020","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.anndiagpath.2022.152006_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052466","article-title":"On the interplay of telomeres, nevi and the risk of melanoma","volume":"7","author":"Bodelon","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152006_bb0165","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2011.05.051","article-title":"Integrating clinical\/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features","volume":"66","author":"Nardone","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152006_bb0170","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/PAS.0000000000000189","article-title":"Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases","volume":"38","author":"North","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0175","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e318222a634","article-title":"Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma","volume":"35","author":"North","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152006_bb0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/DAD.0000000000001341","article-title":"Melanocytic skin neoplasms: what lesson from genomic aberrations?","volume":"4199","author":"Urso","year":"2019","journal-title":"Am J Dermatopathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913422001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:35Z","timestamp":1761078935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913422001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"alternative-id":["S1092913422001083"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152006","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152006"}}